DE602007008952D1 - Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs - Google Patents

Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs

Info

Publication number
DE602007008952D1
DE602007008952D1 DE602007008952T DE602007008952T DE602007008952D1 DE 602007008952 D1 DE602007008952 D1 DE 602007008952D1 DE 602007008952 T DE602007008952 T DE 602007008952T DE 602007008952 T DE602007008952 T DE 602007008952T DE 602007008952 D1 DE602007008952 D1 DE 602007008952D1
Authority
DE
Germany
Prior art keywords
hydrogen
halo
cancer
treatment
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008952T
Other languages
German (de)
English (en)
Inventor
Hong-Yu Li
Harold Burns Brooks
Joyce Z Crich
James Robert Henry
Melissa Kate Slater
Yan Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE602007008952D1 publication Critical patent/DE602007008952D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602007008952T 2006-12-21 2007-12-11 Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs Active DE602007008952D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87130206P 2006-12-21 2006-12-21
PCT/US2007/087044 WO2008076704A1 (en) 2006-12-21 2007-12-11 Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer

Publications (1)

Publication Number Publication Date
DE602007008952D1 true DE602007008952D1 (de) 2010-10-14

Family

ID=39186811

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008952T Active DE602007008952D1 (de) 2006-12-21 2007-12-11 Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs

Country Status (14)

Country Link
US (1) US8101628B2 (cg-RX-API-DMAC10.html)
EP (1) EP2125793B1 (cg-RX-API-DMAC10.html)
JP (1) JP5166441B2 (cg-RX-API-DMAC10.html)
KR (1) KR101088291B1 (cg-RX-API-DMAC10.html)
CN (1) CN101563342B (cg-RX-API-DMAC10.html)
AT (1) ATE479680T1 (cg-RX-API-DMAC10.html)
AU (1) AU2007334039B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0721045A2 (cg-RX-API-DMAC10.html)
CA (1) CA2671738A1 (cg-RX-API-DMAC10.html)
DE (1) DE602007008952D1 (cg-RX-API-DMAC10.html)
EA (1) EA016177B1 (cg-RX-API-DMAC10.html)
ES (1) ES2349169T3 (cg-RX-API-DMAC10.html)
MX (1) MX2009006634A (cg-RX-API-DMAC10.html)
WO (1) WO2008076704A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2125794T1 (sl) 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
EA016781B1 (ru) * 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds
CN108853111B (zh) * 2018-08-07 2020-06-05 浙江大学 一种组合物在制备治疗吉非替尼肝脏毒性药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
WO2004063192A1 (en) * 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
JP2007533602A (ja) * 2003-07-31 2007-11-22 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 置換ベンゾチオフェン化合物及びそれらの使用
AU2005316312B2 (en) 2004-12-17 2009-10-22 Amgen, Inc. Aminopyrimidine compounds and methods of use
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8008481B2 (en) * 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
SI2125794T1 (sl) 2006-12-21 2011-02-28 Lilly Co Eli Spojine imidazolidinonil aminopirimidina za zdravljenje raka
EA016781B1 (ru) 2007-05-16 2012-07-30 Эли Лилли Энд Компани Триазолиламинопиримидиновые соединения
WO2008144222A2 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds

Also Published As

Publication number Publication date
MX2009006634A (es) 2009-06-30
EA016177B1 (ru) 2012-02-28
KR101088291B1 (ko) 2011-11-30
AU2007334039A1 (en) 2008-06-26
BRPI0721045A2 (pt) 2014-07-29
US20100076001A1 (en) 2010-03-25
WO2008076704A1 (en) 2008-06-26
ES2349169T3 (es) 2010-12-28
KR20090086114A (ko) 2009-08-10
EA200970615A1 (ru) 2009-10-30
CN101563342A (zh) 2009-10-21
ATE479680T1 (de) 2010-09-15
US8101628B2 (en) 2012-01-24
JP2010513552A (ja) 2010-04-30
EP2125793B1 (en) 2010-09-01
CA2671738A1 (en) 2008-06-26
EP2125793A1 (en) 2009-12-02
CN101563342B (zh) 2012-09-05
AU2007334039B2 (en) 2012-02-16
JP5166441B2 (ja) 2013-03-21

Similar Documents

Publication Publication Date Title
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
JO3007B1 (ar) مركبات و تركيبات كمثبطات كيناز بروتين
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
EA201000100A1 (ru) Гетероциклические соединения, полезные в качестве ингибиторов mk2
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
UA102251C2 (ru) Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
TW200612936A (en) Indole derivatives
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
EA201170344A1 (ru) Азаиндольные ингибиторы iap
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
MX2010007543A (es) Inhibidores de iap.
DE602007011434D1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
TW200716547A (en) Piperidin-4-yl-amide derivatives
DK1809288T3 (da) Anvendelse af 1,4-bis-(3-aminoalkyl)piperazinderivater ved behandling af neurodegenerative sygdomme
ATE479680T1 (de) Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN